Xiangyi Kong
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 2%
- Pulmonary and Respiratory Medicine top 5%
- Surgery top 10%
- Topics
- Cancer Immunotherapy and Biomarkers (24 papers)Glioma Diagnosis and Treatment (15 papers)Breast Cancer Treatment Studies (14 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xiangyi Kong
185 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Molecular Biology 1.0k
- Oncology 783
- Cancer Research 692
- Pulmonary and Respiratory Medicine 597
- Surgery 397
Countries citing papers authored by Xiangyi Kong
This map shows the geographic impact of Xiangyi Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyi Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyi Kong more than expected).
Fields of papers citing papers by Xiangyi Kong
This network shows the impact of papers produced by Xiangyi Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyi Kong. The network helps show where Xiangyi Kong may publish in the future.
Co-authorship network of co-authors of Xiangyi Kong
This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyi Kong. A scholar is included among the top collaborators of Xiangyi Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyi Kong. Xiangyi Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 5 | |
| 6 | 5 | |
| 7 | 3 | |
| 8 | 2 | |
| 9 | 1 | |
| 10 | 0 | |
| 11 | 15 | |
| 12 | 105 | |
| 13 | 13 | |
| 14 | 9 | |
| 15 | 29 | |
| 16 | 24 | |
| 17 | 72 | |
| 18 | 6 | |
| 19 | 24 | |
| 20 | 16 |
About Xiangyi Kong
Xiangyi Kong is a scholar working on Cancer Research, Oncology and Genetics, having authored 202 papers that have together received 3.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (24 papers), Glioma Diagnosis and Treatment (15 papers) and Breast Cancer Treatment Studies (14 papers). The work is most often cited by research in Cancer Research (692 citations), Oncology (783 citations) and Biological Psychiatry (51 citations). Xiangyi Kong has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yi Fang, Zhongzhao Wang, Jun Gao, Xiangyu Wang, Kuo Chu Hwang, Yi Fang, Yihang Qi, Yanguo Kong, Renzhi Wang and Jie Zhai. Their work appears in journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.